Clinical trials
Phase 3 Adenocarcinoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 3 |
| Eli Lilly and Company | 2 |
| Ariad Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Daiichi Sankyo | 1 |
| Genzyme, a Sanofi Company | 1 |
| Hoffmann-La Roche | 1 |
| NuCana plc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 14 |
| Neoplasms | 7 |
| Stomach Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma | 3 |
| Carcinoma, Large Cell | 2 |
| Carcinoma, Squamous Cell | 2 |
| Digestive System Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.